by Tré LaRosa | Dec 30, 2022 | Featured
By Tré LaRosa NeuLine Health The origins of the FDA’s Patient-Focused Drug Development Program Around ten years ago, the Food and Drug Administration (FDA) acknowledged the unmet need — and urgency — of including patient perspective in drug and device development in a...
by Tré LaRosa | Dec 30, 2022 | Featured
By Tré LaRosa NeuLine Health PROs and clinical trials While patient-reported outcomes are becoming increasingly standard in clinical trials, their impact still needs to be fully understood. Clinical trials, like peer-reviewed journals, face scrutiny and require...
by Tré LaRosa | Dec 13, 2022 | Featured
By Tré LaRosa NeuLine Health Interest — social, financial, and academic — in artificial intelligence has exploded in the last decade: Since 2016, an ETF focused on artificial intelligence and robotics has jumped 148%. A basic PubMed search for “artificial...
by Tré LaRosa | Nov 18, 2022 | Brain Health, Featured
By Tré LaRosa NeuLine Health Interest — social, financial, and academic — in artificial intelligence has exploded in the last decade: Since 2016, an ETF focused on artificial intelligence and robotics has jumped 148%. A basic PubMed search for “artificial...
by Tré LaRosa | Nov 17, 2022 | Alzheimer's, Dementia, Featured
By Tré LaRosaNeuLine Health One devastating consequence of dementias is how they degrade a person’s sense of self. This aspect of dementia has a crater-sized impact on those with dementia, but the progressive cognitive decline also enacts compounded suffering...
Recent Comments